CorMedix Inc. / Fundamentals
Income statement
- Net revenue
€104.66M - Cost of goods sold
€4.58M - Gross profit
€100.08M - SG&A expenses
€2.72B - R&D expenses
€2.11B - EBITDA
€45.08M - D&A
€387.26K - EBIT
€42.49M - Interest expenses
€31.61K - EBT
€44.53M - Tax expenses
€449.30K - Net income
€44.08M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€40.43B - Changes in working capital
-€25.95M - Operating cash flow
€26.25M - Capex
€16.92K - Other investing cash flow
-€29.37M - Net investing cash flow
-€17.58B - Total cash dividends paid
€0.00 - Issuance of common stock
€93.15M - Debt repayment
€0.00 - Other financing cash flow
€636.40K - Net financing cash flow
€98.81M - Foreign exchange effects
€11.20 - Net change in cash
€112.66M - Cash at end of period
€137.34B - Free cash flow
€26.26M
Balance sheet
- Cash and cash equivalents
€137.25B - Cash and short-term investments
€164.31B - Total receivables
€36.97M - Inventory
€8.30B - Other current assets
€41.07B - Total current assets
€213.71B - Property, plant & equipment
€1.77B - Goodwill
€0.00 - Intangible assets
€1.50B - Long-term investments
€90.54K - Other non-current assets
€643.62M - Total non-current assets
€3.91B - Total assets
€217.63B - Accounts payable
€5.01M - Short-term debt
€305.28K - Other current liabilities
€27.32B - Total current liabilities
€27.32B - Long-term debt
€222.56M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€222.34M - Total liabilities
€27.54B - Common stock
€64.29M - Retained earnings
-€257.74B - Other equity
€68.44K - Total equity
€190.08B - Total liabilities and shareholders' equity
€217.63B
Company information
- Market capitalization
€723.14M - Employees
64 - Enterprise Value
€923.75M
Company ratios
- Gross margin
-
95.6% Much better than peer group: -3,329.9% - EBITDA margin
-
43.1% Much better than peer group: -307,610.7% - EBIT margin
-
40.6% Much better than peer group: -315,447.8% - EBT margin
-
42.5% Much better than peer group: -309,377.8% - Net margin
-
42.1% Much better than peer group: -296,778.4% - ROE
-
0.0% Much better than peer group: -3,054.0% - ROA
-
0.0% Much better than peer group: -47.9% - Asset turnover
-
0.0% Much worse than peer group: 322,059.4% - FCF margin
-
25.1% Much better than peer group: -246,665.3% - FCF yield
3.6% - Efficiency ratio
56.9% - Net sales per employee
-
€1.64M - Net income per employee
-
€688.69K